Literature DB >> 9766427

Understanding and controlling the scarring response: the contribution of histology and microscopy.

J T Daniels1, N L Occleston, J G Crowston, M F Cordeiro, R A Alexander, M Wilkins, R Porter, R Brown, P T Khaw.   

Abstract

In response to injury, the body usually initiates a full and swift wound healing response resulting in reconstructed, repaired tissue. In certain instances, due to a variety of factors, this may not happen, an example being chronic granulating venous leg ulcers. At the other extreme, the wound may heal excessively, producing disabling hypertrophic scarring such as can occur following large, deep burn injuries. Our group is interested in the surgical treatment of the eye disease glaucoma. As will be explained, the successful surgical treatment of this disease depends on a reduced scarring response at the end of wound healing. The purpose of this article is to give an overview of our microscopic and histological experimental work which has furthered our understanding of tissue repair, particularly the scarring response and its potential modification for successful glaucoma surgery.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9766427     DOI: 10.1002/(SICI)1097-0029(19980901)42:5<317::AID-JEMT3>3.0.CO;2-M

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  9 in total

1.  Nanolayered siRNA delivery platforms for local silencing of CTGF reduce cutaneous scar contraction in third-degree burns.

Authors:  Steven A Castleberry; Alexander Golberg; Malak Abu Sharkh; Saiqa Khan; Benjamin D Almquist; William G Austen; Martin L Yarmush; Paula T Hammond
Journal:  Biomaterials       Date:  2016-04-14       Impact factor: 12.479

2.  Comparison of fornix- and limbus-based conjunctival flaps in mitomycin C trabeculectomy with laser suture lysis in Japanese glaucoma patients.

Authors:  Takeo Fukuchi; Jun Ueda; Kiyoshi Yaoeda; Kieko Suda; Masaaki Seki; Haruki Abe
Journal:  Jpn J Ophthalmol       Date:  2006 Jul-Aug       Impact factor: 2.447

3.  Mediation of transforming growth factor-beta(1)-stimulated matrix contraction by fibroblasts: a role for connective tissue growth factor in contractile scarring.

Authors:  Julie T Daniels; Gregory S Schultz; Timothy D Blalock; Qian Garrett; Gary R Grotendorst; Nicholas M Dean; Peng T Khaw
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

4.  Phospholipases A2 in normal human conjunctiva and from patients with primary open-angle glaucoma and exfoliation glaucoma.

Authors:  Minna Helin; Seppo Rönkkö; Tuomo Puustjärvi; Markku Teräsvirta; Hannu Uusitalo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-01-15       Impact factor: 3.117

5.  [Long-term results after trabeculectomy with 5-fluorouracil].

Authors:  A Koutsonas; A Remky; N Plange
Journal:  Ophthalmologe       Date:  2014-08       Impact factor: 1.059

6.  SPARC is expressed in scars of the Tenon's capsule and mediates scarring properties of human Tenon's fibroblasts in vitro.

Authors:  Rudolf Fuchshofer; Ulrike B Kottler; Anne V Ohlmann; Ursula Schlötzer-Schrehardt; Anselm Jünemann; Friedrich E Kruse; Andreas Ohlmann
Journal:  Mol Vis       Date:  2011-01-19       Impact factor: 2.367

7.  A Pilot Study on Ocular Safety and Efficacy of Infliximab as an Antifibrotic Agent After Experimental Glaucoma Filtration Surgery.

Authors:  Eleni Nikita; Alexandre Moulin; Ioannis Vergados; Dimitrios Brouzas; Panagiotis G Theodossiadis
Journal:  Ophthalmol Ther       Date:  2017-07-01

8.  Effects of ranibizumab on TGF-β1 and TGF-β2 production by human Tenon's fibroblasts: An in vitro study.

Authors:  Siti Munirah Md Noh; Siti H Sheikh Abdul Kadir; Jonathan G Crowston; Visvaraja Subrayan; Sushil Vasudevan
Journal:  Mol Vis       Date:  2015-10-14       Impact factor: 2.367

Review 9.  Cell-Matrix Interactions in the Eye: From Cornea to Choroid.

Authors:  Andrew E Pouw; Mark A Greiner; Razek G Coussa; Chunhua Jiao; Ian C Han; Jessica M Skeie; John H Fingert; Robert F Mullins; Elliott H Sohn
Journal:  Cells       Date:  2021-03-20       Impact factor: 7.666

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.